CTRI/2024/06/068713
Not yet recruiting
未知
Real-World Treatment Patterns and Clinical Outcomes Among Patients with Urothelial Carcinoma (UC) in India - NI
Pfizer Products India Private Limited0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Pfizer Products India Private Limited
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients of high risk NMIBC who both initiated treatment and/or diagnosed Jan 2023 onwards.
- •All patients of metastatic urothelial carcinoma who initiated treatment and/or diagnosed Jan 2023 onwards.
- •Aged at least 18 years upon diagnosis.
Exclusion Criteria
- •Previously enrolled in an interventional trial related to High\-risk NMIBC or mUC
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Scientific data review of prostate cancer patients to study treatment patterns and understand need gaps.Health Condition 1: N428- Other specified disorders of prostateCTRI/2024/08/072504Pfizer Limited
Not yet recruiting
Not Applicable
Real world study of Advanced Prostate Cancer patients in IndiaCTRI/2024/06/068779Pfizer Products India Private Limited
Completed
Not Applicable
Real World Treatment Patterns and Clinical Outcomes in Unfit AML Patients Receiving First Line Systemic Treatment or Best Supportive Care (CURRENT)Acute myeloid leukemiaJPRN-UMIN000037786AbbVie Inc.1,762
Not yet recruiting
Not Applicable
Real-world treatment patterns and clinical outcomes among patients with stage I-? non-small cell lung cancer in South KoreaKCT0006723Asan Medical Center4,000
Not yet recruiting
Not Applicable
Clinical presentation, Management, Treatment and Outcome of COVID patientsHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereCTRI/2020/07/026510Hindu Mission Hospital